Study Comparing Neurocognitive Functions In High Grade Glioma Receiving Radiation post operatively by treatment according to 2 different tumour delineation techniques
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: C718- Malignant neoplasm of overlappingsites of brain
- Registration Number
- CTRI/2021/09/036822
- Lead Sponsor
- AIIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with histologically proven WHO grade III and IV tumours
2.Hb > 10gm%.
3.Pretreatment leucocyte count of > 4000/cu mm
4.Platelet count > 100,000/cu mm
5.Normal renal and liver function tests
Exclusion Criteria
1.Multicentric Glioblastoma
2.Previously treated primary brain tumours
3.Patients with visual disturbances who will not be able to read the questionnaires provided
4.Patients with Alzheimerâ??s disease, Parkinsonâ??s disease, any form of Dementia
5.Contraindications for MRI examination or gadolinium agent use
6.Pregnant or Nursing mothers
7.Any proven 1p19q co-deleted anaplastic oligodendroglioma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eurocognitive functions <br/ ><br>Timepoint: Assessment at 6 months
- Secondary Outcome Measures
Name Time Method Quality of life <br/ ><br>Progression Free SurvivalTimepoint: Assessment 6 months